 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «1234 |
- | midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion: Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD (clinicaltrials.gov) - Jun 8, 2017
P2, N=27, Completed, Sponsor: Multidisciplinary Association for Psychedelic Studies
Active, not recruiting --> Completed
- | midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion: Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD (clinicaltrials.gov) - Jun 7, 2017
P2, N=10, Completed, Sponsor: Multidisciplinary Association for Psychedelic Studies
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial primary completion date: Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD (clinicaltrials.gov) - Mar 27, 2017
P2, N=27, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Feb 2017
- | midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial primary completion date: Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD (clinicaltrials.gov) - Mar 24, 2017
P2, N=10, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Dec 2015 --> Feb 2017 Trial primary completion date: Feb 2016 --> Sep 2016
- | Trial primary completion date: Randomized, Double-blind, Active Placebo-Controlled Pilot Study of MDMA-assisted Psychotherapy in People With Chronic PTSD (clinicaltrials.gov) - Mar 22, 2017
P2, N=10, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Feb 2016 --> Sep 2016 Trial primary completion date: Mar 2017 --> Jun 2017
- | Trial primary completion date: Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults (clinicaltrials.gov) - Mar 17, 2017
P2, N=12, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Mar 2017 --> Jun 2017 Trial primary completion date: Dec 2016 --> Jul 2017
- | midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment closed, Trial primary completion date: MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness (clinicaltrials.gov) - Mar 17, 2017
P2, N=18, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Dec 2016 --> Jul 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Aug 2017
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion: Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder (clinicaltrials.gov) - Feb 14, 2017
P2, N=26, Completed, Sponsor: Multidisciplinary Association for Psychedelic Studies
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Aug 2017 Active, not recruiting --> Completed
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial primary completion date: MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD (clinicaltrials.gov) - Feb 13, 2017
P1/2, N=20, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Active, not recruiting --> Completed Trial primary completion date: Nov 2016 --> Jul 2017
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial primary completion date: MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness (clinicaltrials.gov) - Oct 13, 2016
P2, N=18, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Nov 2016 --> Jul 2017 Trial primary completion date: Sep 2016 --> Dec 2016
- Enrollment change, Trial initiation date, Trial primary completion date: Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (clinicaltrials.gov) - Oct 6, 2016
P1, N=100, Enrolling by invitation, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Sep 2016 --> Dec 2016 N=20 --> 100 | Initiation date: Mar 2011 --> Oct 2011 | Trial primary completion date: Jun 2017 --> Jun 2018
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial primary completion date: Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD (clinicaltrials.gov) - Sep 13, 2016
P2, N=12, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
N=20 --> 100 | Initiation date: Mar 2011 --> Oct 2011 | Trial primary completion date: Jun 2017 --> Jun 2018 Trial primary completion date: Jun 2016 --> Oct 2016
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
New P1/2 trial: MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD (clinicaltrials.gov) - Aug 22, 2016
P1/2, N=20, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
- Trial primary completion date: Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults (clinicaltrials.gov) - Jul 23, 2016
P2, N=12, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Jun 2016 --> Oct 2016 Trial primary completion date: Jun 2016 --> Dec 2016
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial primary completion date: Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder (clinicaltrials.gov) - Jul 23, 2016
P2, N=24, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Jun 2016 --> Dec 2016 Trial primary completion date: Mar 2016 --> Aug 2016
- Enrollment open: Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults (clinicaltrials.gov) - May 4, 2016
P2, N=12, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Mar 2016 --> Aug 2016 Active, not recruiting --> Recruiting
- Trial primary completion date: Randomized, Double-blind, Active Placebo-Controlled Pilot Study of MDMA-assisted Psychotherapy in People With Chronic PTSD (clinicaltrials.gov) - Mar 16, 2016
P2, N=10, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Active, not recruiting --> Recruiting Trial primary completion date: Jan 2016 --> Mar 2017
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion: Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial (clinicaltrials.gov) - Feb 11, 2016
P2, N=3, Completed, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Jan 2016 --> Mar 2017 Active, not recruiting --> Completed
- Enrollment closed: Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults (clinicaltrials.gov) - Jan 15, 2016
P2, N=12, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion: MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder (clinicaltrials.gov) - Dec 9, 2015
P2, N=23, Completed, Sponsor: Multidisciplinary Association for Psychedelic Studies
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment closed: Randomized, Double-blind, Active Placebo-Controlled Pilot Study of MDMA-assisted Psychotherapy in People With Chronic PTSD (clinicaltrials.gov) - Nov 27, 2015
P2, N=10, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial primary completion date: Randomized, Double-blind, Active Placebo-Controlled Pilot Study of MDMA-assisted Psychotherapy in People With Chronic PTSD (clinicaltrials.gov) - Sep 24, 2015
P2, N=10, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2015 --> Jan 2016
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment closed, Trial primary completion date: Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD (clinicaltrials.gov) - Aug 25, 2015
P2, N=10, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Trial primary completion date: Jun 2015 --> Jan 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Sep 2015
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment closed: Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD (clinicaltrials.gov) - Aug 25, 2015
P2, N=23, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Sep 2015 Recruiting --> Active, not recruiting
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment closed: Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder (clinicaltrials.gov) - May 13, 2015
P2, N=24, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
New P2 trial: MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness (clinicaltrials.gov) - Apr 30, 2015
P2, N=18, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment closed, Trial primary completion date: Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial (clinicaltrials.gov) - Apr 7, 2015
P2, N=3, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Recruiting --> Active, not recruiting Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jan 2014 --> May 2015
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment change: Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD (clinicaltrials.gov) - Mar 14, 2015
P2, N=23, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jan 2014 --> May 2015 N=12 --> 23
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment closed: Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD (clinicaltrials.gov) - Mar 14, 2015
P2, N=12, Active, not recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
N=12 --> 23 Recruiting --> Active, not recruiting
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
New P2 trial: Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD (clinicaltrials.gov) - Apr 1, 2014
P2, N=10, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment open: Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD (clinicaltrials.gov) - Mar 30, 2014
P2, N=10, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Enrollment open: Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults (clinicaltrials.gov) - Feb 23, 2014
P2, N=12, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- New P2 trial: Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults (clinicaltrials.gov) - Dec 9, 2013
P2, N=12, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
New P2 trial: Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD (clinicaltrials.gov) - Oct 7, 2013
P2, N=12, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment open: Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD (clinicaltrials.gov) - Oct 6, 2013
P2, N=12, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment open: Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD (clinicaltrials.gov) - Apr 10, 2013
P2, N=12, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
New P2 trial: Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD (clinicaltrials.gov) - Feb 13, 2013
P2, N=12, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
- New P2 trial: Randomized, Double-blind, Active Placebo-Controlled Pilot Study of MDMA-assisted Psychotherapy in People With Chronic PTSD (clinicaltrials.gov) - Sep 19, 2012
P2, N=10, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment change: Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder (clinicaltrials.gov) - Apr 17, 2012
P2, N=24, Recruiting, Sponsor: Multidisciplinary Association for Psychedelic Studies
Not yet recruiting --> Recruiting N=16 --> 24
- midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
New P2 trial: Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial (clinicaltrials.gov) - Oct 11, 2011
P2, N=3, Enrolling by invitation, Sponsor: Multidisciplinary Association for Psychedelic Studies